Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd

¥14.61As of Sun 8 Nov 2026, 12:00 UTC
SZSE:000766Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (2.78%)
Div yield —
ROE 0.48%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.59
PE TTM 1,127
TSR TTM (43.66%)
Mkt cap ¥14.12B
ROIC 1.77%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥16
9.76%
(97.99%)
Hold 4|7|7|8|6
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.22
0.22
0.23
0.25
13.71%
7.54%
15.05%
18.92%
Revenue¥M
606.4
640.5
645.3
635.1
(0.91%)
7.77%
10.76%
6.57%
Peers (US$2.117B)
Cap (US$)
PE
2.149B
33.99x
2.143B
114.8x
2.114B
13.71x
Capital
TTM
5Y
10Y
Leveragex
6.775
(0.146)
(0.129)
EBIT/Intx
0.623
0.906
0.871
Own earn%
(43.92)
28.37
32.46
Sh yield%
16.93
48.29
46.71
Owners
Insiders/Inst%
2.54
28.11
Short interest%
5.73
SBC / revenue%
4.43
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
2–7
$1 testx
−0.1
Incr. ROIC%
50